| Literature DB >> 28070516 |
Jaroslava Hybášková1, Ondřej Jor2, Vilém Novák3, Karol Zeleník4, Petr Matoušek4, Pavel Komínek4.
Abstract
The present study evaluated whether drug-induced sleep endoscopy (DISE) helps identify the site of obstruction in patients with obstructive sleep apnoea (OSA). A total of 51 consecutive patients with polysomnography-confirmed OSA were enrolled in this prospective study. The presumed site of obstruction was determined according to history, otorhinolaryngologic examination, and polysomnography and a therapeutic plan designed before DISE. In 11 patients with severe OSA and/or previously failed continuous positive airway pressure (CPAP) treatment, DISE with simultaneous CPAP was performed. Multilevel collapse was noted in 49 patients (96.1%). The most frequent multilevel collapse was palatal, oropharyngeal, and tongue base collapse (n = 17, 33.3%), followed by palatal and oropharyngeal collapse (n = 12, 23.5%). Pathology of the larynx (epiglottis) was observed in 16 patients (31.4%). The laryngeal obstruction as a reason for intolerance of CPAP was observed in 3/11 (27.3%) patients. After DISE, the surgical plan was changed in 31 patients (60.8%). The results indicate that DISE helps identify the site of obstruction in the upper airways in patients with OSA more accurately and that the larynx plays an important role in OSA.Entities:
Mesh:
Substances:
Year: 2016 PMID: 28070516 PMCID: PMC5192321 DOI: 10.1155/2016/6583216
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Indication and contraindication for drug-induced sleep endoscopy.
| Indication | (i) 18-65 years old |
|
| |
| Contraindication | (i) ASA 4 |
OSA, obstructive sleep apnoea; AHI, apnoea-hypopnoea index; ASA, American Society of Anesthesiologists.
Figure 1Drug-induced sleep endoscopy with CPAP.
Baseline patient characteristics.
| Variable | All subjects ( |
|---|---|
| Males | 47 (92.2%) |
| Age, years | 44.7 ± 11.3 |
| BMI, kg/m2 | 30.1 ± 4.0 |
| AHI, per hour sleep | 28.4 ± 16.6 |
Data are presented as n (%) or mean ± SD. BMI, body mass index; AHI, apnoea-hypopnoea index.
Type of obstruction in the upper airway.
| Type of collapse in upper airway | Number of patients ( |
|---|---|
|
|
|
| (i) Concentric | 27 (54.0%) |
| (ii) Anteroposterior | 21 (42.0%) |
| (iii) Laterolateral | 2 (4.0%) |
|
|
|
| (i) Concentric | 1 (2.2%) |
| (ii) Laterolateral | 44 (97.8%) |
|
|
|
| (i) Anteroposterior | 31 (100.0%) |
|
|
|
| (i) Laterolateral | 2 (12.5%) |
| (ii) Anteroposterior | 14 (87.5%) |
Type of multilevel collapse in the upper airway.
| Type of multilevel collapse | Number of patients |
|---|---|
| Palatal + base of tongue | 4 (7.9%) |
| Palatal + base of tongue + epiglottis | 1 (2.0%) |
| Palatal + oropharyngeal | 12 (23.5%) |
| Palatal + oropharyngeal + epiglottis | 6 (11.8%) |
| Palatal + oropharyngeal + base of tongue | 17 (33.3%) |
| Palatal + oropharyngeal + base of tongue + epiglottis | 9 (17.6%) |
Change in indication to operation after drug-induced sleep endoscopy (DISE).
| Indication for surgery in wakefulness after ENT examination | Indication for surgery after DISE (jaw thrust was done as a part of DISE in all patients) | Number of patients ( |
|---|---|---|
| UPPP | UPPP + RFBT | 7 (22.6%) |
| UPPP | Epiglottopexy | 1 (3.2%) |
| UPPP | UPPP + epiglottopexy | 2 (6.4%) |
| UPPP | UPPP + RFBT + epiglottopexy | 1 (3.2%) |
| RFBT | UPPP | 1 (3.2%) |
| RFBT | Mandibular advancement | 1 (3.2%) |
| UPPP + RFBT | UPPP | 8 (25.1%) |
| UPPP + RFBT | UPPP + epiglottopexy | 3 (9.7%) |
| UPPP + RFBT | UPPP + RFBT + epiglottopexy | 4 (12.9%) |
| UPPP + RFBT | RFBT + epiglottopexy | 1 (3.2%) |
| UPPP + RFBT | Mandibular advancement | 1 (3.2%) |
UPPP, uvulopalatopharyngoplasty; RFBT, radiofrequency base of the tongue.
Figure 2Collapsed epiglottis on the posterior wall of the hypopharynx during drug-induced sleep endoscopy. The condition caused apnoea.